HIGHLIGHTS
- who: Ji Liu and colleagues from the Department of Urology, Shanghai Tenth People`s Hospital, School of Medicine, Tongji University, Shanghai, China have published the article: Down-Regulation of lncRNA MBNL1-AS1 Promotes Tumor Stem Cell-like Characteristics and Prostate Cancer Progression through miR-221-3p/CDKN1B/C-myc Axis, in the Journal: Cancers 2022, 5783 of /2022/
- what: This study demonstrated that the group with low expression of MBNL1-AS1 and CDKN1B was less sensitive to chemotherapy compared to Wnt signaling pathway inhibitors, which may suggest that MBNL1-AS1 and CDKN1B can inhibit the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.